|
Transplantation
Citations 11-20 of 1455 total displayed.
|
Past content
(since Jan 1997):
|
Cytotoxic T lymphocyte therapy with donor T cells prevents and treats adenovirus and Epstein-Barr virus infections after haploidentical and matched unrelated stem cell transplantation
- Ann M. Leen, Anne Christin, Gary D. Myers, Hao Liu, Conrad R. Cruz, Patrick J. Hanley, Alana A. Kennedy-Nasser, Kathryn S. Leung, Adrian P. Gee, Robert A. Krance, Malcolm K. Brenner, Helen E. Heslop, Cliona M. Rooney, and Catherine M. Bollard
Blood 2009; 114: 4283-4292.
[Abstract]
[Full text]
[PDF]
Relapse risk after umbilical cord blood transplantation: enhanced graft-versus-leukemia effect in recipients of 2 units
- Michael R. Verneris, Claudio G. Brunstein, Juliet Barker, Margaret L. MacMillan, Todd DeFor, David H. McKenna, Michael J. Burke, Bruce R. Blazar, Jeffrey S. Miller, Philip B. McGlave, Daniel J. Weisdorf, and John E. Wagner
Blood 2009; 114: 4293-4299.
[Abstract]
[Full text]
[PDF]
Safety and efficacy of hematopoietic stem cell collection from mobilized peripheral blood in unrelated volunteers: 12 years of single-center experience in 3928 donors
- Kristina Hölig, Michael Kramer, Frank Kroschinsky, Martin Bornhäuser, Thilo Mengling, Alexander H. Schmidt, Claudia Rutt, and Gerhard Ehninger
Blood 2009; 114: 3757-3763.
[Abstract]
[Full text]
[PDF]
Depletion of endogenous tumor-associated regulatory T cells improves the efficacy of adoptive cytotoxic T-cell immunotherapy in murine acute myeloid leukemia
- Qing Zhou, Christoph Bucher, Meghan E. Munger, Steven L. Highfill, Jakub Tolar, David H. Munn, Bruce L. Levine, Megan Riddle, Carl H. June, Daniel A. Vallera, Brenda J. Weigel, and Bruce R. Blazar
Blood 2009; 114: 3793-3802.
[Abstract]
[Full text]
[PDF]
Harnessing the physiology of lymphopenia to support adoptive immunotherapy in lymphoreplete hosts
- Yongzhi Cui, Hua Zhang, Joanna Meadors, Rita Poon, Martin Guimond, and Crystal L. Mackall
Blood 2009; 114: 3831-3840.
[Abstract]
[Full text]
[PDF]
The human alloreactive CD4+ T-cell repertoire is biased to a Th17 response and the frequency is inversely related to the number of HLA class II mismatches
- Nicolle H. R. Litjens, Jacqueline van de Wetering, Nicole M. van Besouw, and Michiel G. H. Betjes
Blood 2009; 114: 3947-3955.
[Abstract]
[Full text]
[PDF]
Bortezomib, tacrolimus, and methotrexate for prophylaxis of graft-versus-host disease after reduced-intensity conditioning allogeneic stem cell transplantation from HLA-mismatched unrelated donors
- John Koreth, Kristen E. Stevenson, Haesook T. Kim, Michael Garcia, Vincent T. Ho, Philippe Armand, Corey Cutler, Jerome Ritz, Joseph H. Antin, Robert J. Soiffer, and Edwin P. Alyea, III
Blood 2009; 114: 3956-3959.
[Abstract]
[Full text]
[PDF]
Identification of 4 new HLA-DR–restricted minor histocompatibility antigens as hematopoietic targets in antitumor immunity
- Anita N. Stumpf, Edith D. van der Meijden, Cornelis A. M. van Bergen, Roel Willemze, J. H. Frederik Falkenburg, and Marieke Griffioen
Blood 2009; 114: 3684-3692.
[Abstract]
[Full text]
[PDF]
Cytolytic T cells induce ceramide-rich platforms in target cell membranes to initiate graft-versus-host disease
- Jimmy A. Rotolo, Branka Stancevic, Sydney X. Lu, Jianjun Zhang, David Suh, Christopher G. King, Lucy W. Kappel, George F. Murphy, Chen Liu, Zvi Fuks, Marcel R. van den Brink, and Richard Kolesnick
Blood 2009; 114: 3693-3706.
[Abstract]
[Full text]
[PDF]
Donor-recipient mismatches in MHC class I chain-related gene A in unrelated donor transplantation lead to increased incidence of acute graft-versus-host disease
- Simrit Parmar, Marcos del Lima, Yizhou Zou, Poliana A. Patah, Ping Liu, Pedro Cano, Gabriela Rondon, Susana Pesoa, Leandro de Padua Silva, Muzaffar H. Qazilbash, Chitra Hosing, Uday Popat, Partow Kebriaei, Elizabeth J. Shpall, Sergio Giralt, Richard E. Champlin, Peter Stastny, and Marcelo Fernandez-Vina
Blood 2009; 114: 2884-2887.
[Abstract]
[Full text]
[PDF]
|
|
